Rhabdoid meningioma is a rare and aggressive brain or spinal cord tumor that can cause headaches, seizures, weakness, or changes in thinking and daily function. It often affects adults, but it can occur at other ages too. Not everyone will have the same experience. Early symptoms of rhabdoid meningioma depend on where the tumor is and how fast it grows, and symptoms may develop over weeks to months. Treatment usually involves surgery and often radiation therapy, while outlook can be serious because rhabdoid meningioma has a higher chance of coming back than most other meningiomas.
How many people live with Rhabdoid meningioma?
There is no direct worldwide count for rhabdoid meningioma, but recent Global Burden of Disease work suggests on the order of 1 million to 3 million people worldwide are living with meningioma overall (Global Burden of Disease Study 2019, 2022); since rhabdoid meningioma appears to make up only about 0.1% to 1% of meningiomas, and that share can vary depending on how the tumor is classified, this suggests roughly 1,000 to 30,000 people worldwide may be living with it, which is an estimate rather than a direct count. In the United States, nearly 1 million people are living with a primary brain tumor (American Brain Tumor Association, 2023), and meningiomas make up about 40% of these tumors (CBTRUS, 2024), so using the same 0.1% to 1% range suggests about 400 to 4,000 people in the U.S. may be living with rhabdoid meningioma, again as an estimate rather than a direct count.
Overview
Rhabdoid meningiomaSymptoms
Rhabdoid meningioma can cause headaches, seizures, weakness, or changes in vision, speech, or memory. Symptoms depend on where the tumor presses on the brain or spinal cord. Early symptoms of rhabdoid meningioma can be subtle.
Outlook and prognosis
Rhabdoid meningioma often behaves more aggressively than typical meningiomas, so close follow-up is important even after treatment. Outlook varies with how much tumor can be removed, whether it returns, and where it is located in the brain or spine.
Causes and risk factors
Rhabdoid meningioma often develops from gene changes that happen in tumor cells over time, rather than something inherited. Risk may be higher after prior head radiation, and in some people with inherited conditions such as NF2.
Genetic influences
Genetics matter in rhabdoid meningioma because many cases are linked to changes in tumor genes, especially SMARCB1. These changes usually arise in the tumor itself rather than being inherited. Genetic testing of the tumor can help confirm the diagnosis.
Diagnosis
Rhabdoid meningioma is usually diagnosed with brain or spine imaging, most often MRI. A biopsy or surgery then confirms the diagnosis of rhabdoid meningioma by examining the tumor cells under a microscope.
Treatment and drugs
Treatment for rhabdoid meningioma usually starts with surgery to remove as much of the tumor as is safely possible. Many also need radiation afterward, and some may need close follow-up scans or, less often, medicine through a cancer specialist.
Symptoms
Rhabdoid meningioma can affect daily life in different ways depending on where the tumor is growing and how much pressure it puts on nearby brain tissue. The early symptoms of rhabdoid meningioma are often not unique and can look like other brain conditions, so changes may be mistaken for migraines, stress, or an inner ear problem at first. Symptoms vary from person to person and can change over time. Because this tumor can grow and spread more aggressively than most meningiomas, symptoms may appear or worsen over a shorter time.
Headaches are common and may feel new, stronger, or more persistent than usual. Some people notice they are worse in the morning or when bending over, coughing, or straining.
Seizures can happen even in someone who has never had one before. They may cause shaking, staring spells, brief confusion, or unusual movements in one part of the body.
Pressure on certain parts of the brain can lead to weakness, heaviness, or numbness in an arm, leg, or one side of the face. For many people with rhabdoid meningioma, this may show up as dropping objects, dragging a foot, or trouble with buttons and stairs.
Blurred vision, double vision, or partial vision loss can happen if the tumor affects areas linked to sight or eye movement. Some may also notice trouble reading, judging distance, or keeping their eyes focused.
How people usually first notice Rhabdoid meningioma?
People usually first notice rhabdoid meningioma when new neurologic symptoms start to interrupt daily life, often with headaches that keep coming back, seizures, nausea or vomiting, or changes in vision. Depending on where the tumor is growing, many living with rhabdoid meningioma may also first notice weakness, balance trouble, personality or memory changes, or difficulty speaking, because the mass presses on nearby brain tissue rather than causing one single signature symptom. These warning signs can overlap with many more common conditions, but if they are new, worsening, or happen together, they are a reason to seek prompt medical care so brain imaging can look for the cause.
Types of Rhabdoid meningioma
Rhabdoid meningioma is itself a rare, high-grade subtype of meningioma rather than a condition with several well-established subtypes of its own. Symptoms can still vary depending on where the tumor is in the brain or spinal area and how much pressure it causes. In current medical practice, no distinct types of rhabdoid meningioma are widely recognized.
Can I slow down the onset of symptoms?
No, there is no good evidence that lifestyle changes or routine medicines can meaningfully delay the start of symptoms from rhabdoid meningioma, a rare fast-growing tumor in the tissue around the brain and spinal cord. Healthy habits like staying active, not smoking, sleeping well, and managing blood pressure are good for overall health, but they have not been shown to prevent this tumor or clearly push symptoms back, and there is no routine screening test for most people before symptoms appear. The most helpful step is to take new problems such as ongoing headaches, seizures, weakness, or vision changes seriously and get checked early, which can help with faster treatment even though it cannot guarantee a better outcome.
What genetics can tell you about symptoms
Genetics can sometimes give clues about how rhabdoid meningioma behaves, but they usually do not predict one exact set of symptoms, because symptoms mostly depend on where the tumor is growing and how much pressure it puts on nearby brain tissue. Certain gene changes found in these tumors, especially changes involving NF2 or loss of BAP1, have been linked with faster growth and a more aggressive course, which can mean symptoms start sooner, worsen more quickly, or come back after treatment. In a small number of families, an inherited change such as BAP1 can raise the risk of developing this kind of tumor, but it still cannot reliably tell which symptoms someone will have day to day.
Causes and risk factors
The exact cause of rhabdoid meningioma is often unclear, but it develops from gene changes in the cells that line the brain and spinal cord. Some risks are written in our DNA, passed down through families. Rare inherited conditions such as NF2 or BAP1 changes can raise the risk, and prior radiation to the head is the clearest environmental risk factor for meningiomas. Older age and being female raise the overall risk of meningioma, although this rare subtype can also occur in males and in different age groups. Lifestyle links for rhabdoid meningioma are less certain, but obesity may raise the risk of meningioma overall.
What are the most common causes or risk factors?
The exact cause of rhabdoid meningioma is often not clear, but the strongest known risk factors are past radiation to the head and rare gene changes that affect how cells grow. These gene changes can happen only in the tumor, or more rarely run in families, especially changes linked to NF2 or BAP1, which are genes that normally help keep cell growth under control. Risk also tends to rise with age, although this rare type can occur in younger adults too.
Environmental and biological risk factors
Rhabdoid meningioma is a rare type of meningioma, and its exact causes are not always clear. Research on specific risk factors for rhabdoid meningioma is limited because this subtype is uncommon. Doctors often group risks into internal (biological) and external (environmental).
Previous radiation to the head is the clearest environmental risk factor linked to meningiomas. This risk is strongest after medical radiation treatments, and a tumor may not appear until many years later.
Most meningiomas are diagnosed in adults, especially later in life. Rhabdoid meningioma can occur across a range of ages, but increasing age is still considered a general biological risk factor.
Meningiomas overall are more common in women, which suggests hormone-related body differences may play a role. This pattern is less consistent in high-grade tumors such as rhabdoid meningioma, but sex-based biological influences are still considered relevant.
Some rhabdoid meningiomas develop when an earlier meningioma comes back and changes into a more aggressive form. In these cases, the risk is tied more to the tumor's underlying biology than to a new outside exposure.
Genetic risk factors
Most rhabdoid meningiomas develop after DNA changes arise in the tumor itself, rather than being passed down through a family. The best-known change involves BAP1, and a smaller number of people have an inherited BAP1 change that raises risk. Carrying a genetic change doesn’t guarantee the condition will appear. Other tumor DNA changes, including NF2 loss and damage in other growth-control genes, can also shape how aggressive rhabdoid meningioma becomes.
BAP1 changes: Loss of BAP1 is one of the strongest genetic links to rhabdoid meningioma. When this gene stops working, tumor cells can behave more aggressively and may be more likely to return after treatment. Doctors may test the tumor for BAP1 because it can affect follow-up and family risk questions.
Inherited BAP1: In a small number of people, a BAP1 change is inherited and is present in all the body’s cells from birth. For some families, this is the clearest inherited risk of rhabdoid meningioma. If a tumor shows BAP1 loss, genetic counseling may help clarify whether family testing should be discussed.
NF2 changes: Changes in NF2, a gene that helps control cell growth, are common across meningiomas and can also be found in rhabdoid tumors. Most of these changes are limited to the tumor, but rarely they are part of an inherited condition known as neurofibromatosis type 2, which raises the chance of meningiomas.
CDKN2A/B loss: Some rhabdoid meningiomas lose CDKN2A or CDKN2B, genes that normally act like brakes on cell division. Their loss is mainly a sign of more aggressive tumor biology rather than an inherited risk for most people.
TERT promoter: A smaller group of rhabdoid meningiomas have a change in the TERT promoter, a DNA control region that helps regulate how long cells keep dividing. When this change is present, the tumor often behaves more aggressively.
Lifestyle risk factors
Lifestyle factors are not considered the main drivers of rhabdoid meningioma, and this tumor subtype is primarily defined by its aggressive biology. Still, when people ask about lifestyle risk factors for rhabdoid meningioma, the most relevant modifiable issues are those linked to meningioma risk more broadly rather than this rare subtype alone. The strongest lifestyle-related associations are excess body weight and some forms of hormone exposure, while evidence for diet, exercise, smoking, and alcohol is limited or inconsistent. Lifestyle changes may support overall health during treatment and recovery, but they cannot reliably prevent this tumor.
Obesity has been associated with a higher risk of meningioma in several studies. Higher body fat may alter estrogen, insulin, and inflammatory signaling in ways that could support meningioma development. This link is better established for meningioma overall than for rhabdoid meningioma specifically.
Physical inactivity can contribute to weight gain and poorer metabolic health, which may indirectly raise meningioma risk. Regular exercise may help with weight control, physical resilience, and recovery during treatment, but it has not been proven to specifically prevent rhabdoid meningioma.
Long-term use of certain exogenous hormones, especially some progestin-containing medications, has been linked to higher meningioma risk. This does not mean hormones cause every case, but reviewing hormone therapies with a clinician can be relevant in how lifestyle affects rhabdoid meningioma risk discussions.
No specific diet has been proven to cause or prevent rhabdoid meningioma. However, diets that promote obesity and insulin resistance may indirectly matter because they worsen metabolic patterns linked to meningioma risk overall.
Risk prevention
Rhabdoid meningioma usually cannot be fully prevented, because it often develops without a clear, controllable cause. Prevention is about lowering risk, not eliminating it completely. For many people, the most practical steps are avoiding unnecessary radiation exposure, knowing whether an inherited risk is present, and getting timely follow-up if a meningioma has already been found or treated. Because this tumor can grow aggressively, paying attention to early symptoms of rhabdoid meningioma, such as new headaches, seizures, or vision changes, may also help with earlier diagnosis.
Exposure to ionizing radiation to the head is one of the clearest known risk factors for meningiomas. When imaging or treatment is needed, doctors try to use the lowest appropriate radiation dose and avoid unnecessary exposure.
Some people have an inherited tendency to develop meningiomas, especially with conditions such as NF2. If several relatives have had brain tumors or meningiomas, genetic counseling may help clarify risk and whether screening is worth discussing.
If you have had a meningioma before, regular scans and specialist visits can help find regrowth or a more aggressive tumor earlier. This matters because rhabdoid meningioma can come back faster than more typical meningiomas.
New or worsening headaches, seizures, weakness, balance problems, or changes in vision should not be ignored. While this does not prevent rhabdoid meningioma itself, it can shorten the time to diagnosis and treatment.
Can you prevent Rhabdoid meningioma?
There is no sure way to prevent rhabdoid meningioma, a rare tumor that starts in the lining around the brain or spinal cord, because it often develops without a clear cause. One of the few well-known risks is past radiation to the head, so avoiding unnecessary radiation when possible may lower risk, but many people with this tumor have no known risk factors. If this kind of tumor runs in your family or you have a rare inherited condition linked to tumors, talking with a doctor may help you understand your risk, though it cannot fully prevent it.
Transmission
Rhabdoid meningioma is not infectious, so you cannot catch it from someone through touching, kissing, sex, the air, or shared food and drinks. For most people, rhabdoid meningioma does not run in families and is not passed from parent to child in the usual sense.
When people ask about how rhabdoid meningioma is inherited, the answer is that most cases happen because genetic changes develop in the tumor cells during life rather than being inherited at birth. In a small number of families, there may be an inherited tendency to develop meningiomas, so if several relatives have had similar tumors or someone develops more than one related tumor, genetic counseling may be worth discussing.
When to test your genes
For rhabdoid meningioma, gene testing is usually most useful after diagnosis, not for routine early screening. It is worth discussing if the tumor appears at a young age, if there are multiple meningiomas, or if your family history suggests an inherited syndrome such as NF2 or SMARCB1-related disease, because results can guide surveillance and family counseling.
Diagnosis
Rhabdoid meningioma is usually suspected after symptoms such as headaches, seizures, weakness, or changes in thinking lead to brain imaging. Because this tumor can grow and press on nearby brain tissue, day-to-day problems may build over weeks or months rather than appearing all at once. Doctors usually begin the diagnosis of rhabdoid meningioma with a review of symptoms, a neurologic exam, and imaging, but the final answer usually comes from examining tumor tissue.
Your doctor asks about symptoms, how quickly they started, and whether there have been seizures, headaches, vision changes, or weakness. A detailed family and health history can help rule out more common causes and guide the next tests.
This exam checks strength, sensation, reflexes, balance, speech, and memory. Changes here can help show which part of the brain may be affected and how urgently treatment is needed.
Brain MRI with contrast is usually the main imaging test for suspected rhabdoid meningioma. It can show the tumor’s size, location, pressure on nearby tissue, and whether it has features that suggest a more aggressive meningioma.
CT may be used if symptoms need urgent assessment or if MRI is not possible. It can help show bleeding, swelling, or changes in the skull near the tumor.
How is Rhabdoid meningioma diagnosed?
Rhabdoid meningioma is usually first suspected with a detailed brain or spine scan, most often an MRI, when symptoms such as headaches, seizures, weakness, or changes in vision or thinking lead doctors to look for a tumor. The diagnosis is confirmed by examining a piece of the tumor under a microscope after surgery or a biopsy, which means taking a small sample, because this shows the specific cell pattern that defines this type. Doctors may also test the tumor, and sometimes do genetic testing, to learn more about it and help plan treatment, but the scan and the tumor sample are the main parts of diagnosis.
Stages of Rhabdoid meningioma
Rhabdoid meningioma does not have defined progression stages. That is because it is usually described by how aggressive it looks under the microscope and how it behaves on scans, rather than by a set sequence of step-by-step stages over time. Doctors usually start with a conversation about symptoms, and the condition is then assessed with brain imaging such as MRI and confirmed by examining tumor tissue after surgery or biopsy. In practice, follow-up focuses on signs of growth or return after treatment, so early symptoms of rhabdoid meningioma and regular scan results both help guide care.
Outlook and prognosis
Rhabdoid meningioma generally has a guarded prognosis because it behaves more aggressively than most other meningiomas, with a higher risk of recurrence, brain invasion, and spread within the central nervous system. Outcomes depend on factors such as tumor grade, location, extent of surgical removal, and whether radiation therapy can be given, but even after apparently complete resection, recurrence is common. Published series suggest shorter progression-free survival and overall survival than for typical benign meningiomas, with many patients experiencing recurrence within a few years. Mortality is higher than for lower-grade meningiomas, particularly in tumors that cannot be fully removed or that show additional high-grade features such as marked mitotic activity or necrosis. Close long-term follow-up with repeated imaging is essential, since early detection of regrowth can affect treatment options and outcomes.
Long-term effects
Rhabdoid meningioma can have a more serious long-term outlook than many other meningiomas because it tends to grow back and can affect nearby brain tissue. For many, this can mean ongoing monitoring, repeat treatment, and lasting changes in day-to-day function depending on where the tumor is located. It’s important to remember that long-term doesn’t always mean progressive, but this tumor is considered an aggressive type and needs close follow-up. Thinking about the long-term effects helps set expectations after treatment and over the years ahead.
Rhabdoid meningioma often comes back after surgery, sometimes within a relatively short time. This is one reason people living with rhabdoid meningioma usually need regular brain scans and long-term specialist follow-up.
Lasting weakness, numbness, balance trouble, or vision changes can happen if the tumor or its treatment affects nearby parts of the brain. The exact problems vary by location, so one person may struggle with walking while another notices fine hand tasks are harder.
Some people continue to have seizures or frequent headaches even after treatment, especially if the brain remains irritated or scarred. These can affect driving, work, sleep, and confidence in daily routines.
Problems with attention, memory, planning, or word-finding may persist over time in some people with rhabdoid meningioma. Many living with this tumor describe forgetting appointments, losing track of conversations, or needing more time for familiar tasks.
How is it to live with Rhabdoid meningioma?
Living with rhabdoid meningioma can feel deeply disruptive because this is a rare, aggressive brain tumor, and daily life often starts to revolve around symptoms, treatment, and close follow-up. Many people living with it may face headaches, seizures, changes in thinking or mood, fatigue, or limits on driving, work, and independence, although the exact impact depends on where the tumor is and how it responds to surgery, radiation, and other care. For family and friends, life often changes too, as they may take on caregiving, help with appointments and decisions, and adjust to uncertainty, but strong support, rehabilitation, and palliative care can make day-to-day life safer, more comfortable, and more manageable.
Treatment and drugs
Rhabdoid meningioma is usually treated with surgery first, because removing as much of the tumor as possible can help relieve pressure on the brain or spinal cord and improve symptoms such as headaches, seizures, weakness, or changes in vision. Because this is a rare and more aggressive type of meningioma, radiation therapy is often used after surgery to lower the chance that it will grow back, especially if the tumor could not be fully removed. Treatment plans often combine several approaches. Medicines do not usually shrink rhabdoid meningioma itself, but doctors may prescribe drugs to control symptoms, such as anti-seizure medicine, pain relief, or steroids to reduce swelling around the tumor. Finding the right therapy can take some time, and follow-up scans are an important part of treatment so your care team can watch for regrowth and adjust care if needed.
Can you cure Rhabdoid meningioma?
There is no guaranteed cure for rhabdoid meningioma. Treatment usually involves surgery to remove as much of the tumor as possible, often followed by radiation to lower the chance of it coming back; this can help control the tumor and ease symptoms, but this type of meningioma is fast-growing and often returns.
Non-drug treatment
For many living with rhabdoid meningioma, treatment is centered on procedures and supportive care rather than medicines alone. Because this tumor can grow quickly and is more likely to come back than many other meningiomas, doctors usually plan care with a neurosurgeon, radiation team, and rehabilitation specialists. Day to day, this can mean treatment aimed at removing or shrinking the tumor, then helping with recovery of movement, speech, thinking, or balance. Not every approach works the same way, and the best plan depends on the tumor’s size, location, and whether it has returned after earlier treatment.
Surgery is often the main non-drug treatment for rhabdoid meningioma, with the goal of removing as much of the tumor as is safely possible. This can help reduce pressure on the brain or spinal cord and may ease headaches, weakness, seizures, or vision changes.
Radiation is commonly used after surgery because rhabdoid meningioma has a higher risk of growing back. It uses focused high-energy beams to target leftover tumor cells, and it may also be used when surgery cannot remove the whole tumor safely.
Supportive therapies can help if the tumor or its treatment affects walking, arm strength, speech, swallowing, memory, or daily tasks. Physical, occupational, and speech therapy are often tailored to the areas most affected.
If seizures have happened, non-drug care may include seizure first aid, avoiding risky activities until cleared to resume them, and planning for safe driving, bathing, or work routines. Family members often play a role in supporting new routines and knowing when urgent help is needed.
Your genes may have an impact on how drugs work for you
For people living with rhabdoid meningioma, treatment usually relies more on surgery and radiation than on medicines, so genetic testing to guide drug choice is not a routine part of care for most. Still, inherited differences can sometimes affect how the body breaks down supportive medicines, such as pain drugs, anti-seizure medicines, or treatments for side effects, which can change how well they work or how likely they are to cause problems. In some cases, the tumor’s own genetic changes may also help doctors decide whether a targeted cancer drug is worth considering, but this depends on the exact tumor and is still not the main treatment for many people.
Pharmacological treatments
For many living with rhabdoid meningioma, medicines are usually not the main treatment because surgery and radiation are more often used first. Drug treatment may still help in two important ways: easing symptoms caused by the tumor and offering a systemic option when the tumor comes back or keeps growing after standard care. If one option isn’t effective, second-line or alternative drugs may be offered. Because this tumor is rare and aggressive, there is no single standard medicine that works for everyone.
Dexamethasone is often used to lower swelling around a rhabdoid meningioma in the brain or spine. This can help with headaches, nausea, weakness, or pressure-related symptoms, sometimes within days.
Levetiracetam is commonly used if rhabdoid meningioma has caused seizures, and some people may instead receive drugs such as lacosamide or valproate. These medicines do not shrink the tumor, but they can help prevent further seizure episodes and improve day-to-day safety.
Hydroxyurea is an older chemotherapy drug sometimes used for recurrent or progressive meningioma when surgery or radiation are no longer enough. Its benefit is usually modest, but it may be discussed as part of treatment for recurrent rhabdoid meningioma.
Temozolomide has been tried in some people with aggressive meningiomas, including rhabdoid meningioma, especially after other treatments have failed. Results have generally been limited, so it is not considered a standard first choice.
Genetic influences
After a diagnosis, many living with rhabdoid meningioma want to know whether genes had anything to do with it. It’s natural to ask whether family history plays a role. Most rhabdoid meningiomas are tied to gene changes that happen in the tumor itself over time, rather than a gene change inherited from a parent. Researchers have found changes in genes such as NF2 and, in some tumors, BAP1, and these changes may help explain why rhabdoid meningioma can act more aggressively than some other meningiomas. An inherited risk is much less common, but doctors may think about it if the tumor appears at a younger age, if there is more than one meningioma, or if close relatives have had related tumors. In those situations, a genetics specialist may help decide whether testing could clarify the cause and whether other family members might also need screening.
Is Rhabdoid meningioma genetic?
Genetics matter in rhabdoid meningioma because many cases are linked to changes in tumor genes, especially SMARCB1. These changes usually arise in the tumor itself rather than being inherited. Genetic testing of the tumor can help confirm the diagnosis.
Having a genetic risk is not necessarily a diagnosis
Genetic changes are a normal part of human biology and are widely found in the general population. Most of these variants do not directly affect health and simply reflect natural differences among people. For many genes, having a variant connected to a condition suggests a possible link rather than a certain diagnosis, especially when several genes and environmental factors play a part. In some situations, though, a single well-understood variant in a particular gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For many living with rhabdoid meningioma, treatment choices are influenced more by the tumor’s own genetic changes than by the genes you inherit. Doctors may study the tumor after surgery for changes such as loss of BAP1 or other molecular markers, because these can suggest a more aggressive course and may help identify clinical trials or newer targeted treatment for rhabdoid meningioma. Not every difference in response is genetic, but surgery and radiation are still the main treatments, and there is no routine inherited pharmacogenetic test that reliably picks the best drug for most people with this tumor. When medicines such as chemotherapy, targeted drugs, or immunotherapy are considered, genetic results are usually used to guide research options and estimate likely benefit rather than to guarantee that a drug will work. If testing suggests an inherited BAP1 change, doctors may also recommend genetic counseling, since that can matter for follow-up care and sometimes for close relatives.
Interactions with other conditions
Rhabdoid meningioma can affect daily life not only through the tumor itself, but also by worsening problems caused by other brain or nerve conditions. Having more than one diagnosis can make symptoms feel harder to untangle, especially when headaches, seizures, weakness, or balance trouble could come from the tumor, treatment effects, or another neurologic illness. If rhabdoid meningioma blocks the normal flow of fluid around the brain, it can lead to increased pressure or hydrocephalus, which may overlap with symptoms of stroke, dementia, or inner ear disorders and make diagnosis less straightforward. Many living with rhabdoid meningioma also need close monitoring if they have seizure disorders, blood clotting problems, or significant heart or lung disease, because these can complicate surgery, radiation, and recovery. In some families, meningiomas occur more often with inherited conditions such as neurofibromatosis type 2, so family history can matter when doctors look at the bigger picture. Because this tumor is uncommon and more aggressive than many other meningiomas, coordinated care across neurosurgery, oncology, and neurology is often important when rhabdoid meningioma appears alongside other health issues.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Rhabdoid meningioma?
Other growths in or around the brain, such as more common meningiomas, tumors that start in the brain tissue, or cancer that has spread to the brain from somewhere else in the body, can cause similar problems like headaches, seizures, weakness, or changes in vision, balance, or thinking. Depending on where it is, a rhabdoid meningioma can also be mistaken at first for conditions like stroke, bleeding in the brain, or sometimes even severe migraine, which is why brain scans and a lab check of the tumor are usually needed to tell the difference.
History
Rhabdoid meningioma entered medicine as doctors began to recognize that not all meningiomas behave in the same way. Meningiomas are tumors that arise from the coverings of the brain and spinal cord, and some grow slowly for years, while others act much more aggressively. For people living with rhabdoid meningioma, this history matters because it helps explain why doctors now watch it closely and usually recommend prompt treatment rather than a wait-and-see approach.
First described in the medical literature as a distinct and more aggressive form of meningioma in the late 20th century, rhabdoid meningioma was identified by its unusual appearance under the microscope. Pathologists noticed that some tumor cells had a particular shape and internal structure that set them apart from more common meningiomas. At first, these cases were described mainly by how they looked, but over time doctors also recognized a pattern in how they behaved, including a higher chance of coming back after treatment.
As medical science evolved, classification systems became more refined, and rhabdoid meningioma was grouped among the higher-grade meningiomas because of its tendency to grow and recur more aggressively. This was an important shift. It meant that a diagnosis was no longer based only on what the cells looked like, but also on what that appearance could mean for day-to-day care, follow-up scans, and treatment planning.
In more recent years, advances in imaging, surgery, and pathology have helped doctors diagnose rhabdoid meningioma more accurately than in the past. Researchers also learned that some tumors can show rhabdoid features alongside other meningioma patterns, which is one reason diagnosis may require careful review by specialists. Knowing this history helps explain why early symptoms of rhabdoid meningioma, the scan findings, and the lab results are all considered together when doctors decide on the best care.